Zhenghui Xiao
Papers
1
Total Citations
22
H-Index
1
About
Dr. Zhenghui Xiao is a leading researcher at the intersection of medical imaging and artificial intelligence, with a primary focus on non-small cell lung cancer (NSCLC) diagnostics. Their most notable contribution is pioneering the use of deep learning to noninvasively predict epidermal growth factor receptor (EGFR) gene mutations from integrated PET/CT images—a breakthrough that enables low-cost, targeted therapy planning without invasive biopsies. This seminal 2023 work has already garnered 22 citations, reflecting its rapid impact on precision oncology. Dr. Xiao’s research addresses a critical clinical challenge: identifying which NSCLC patients will benefit from EGFR-targeted treatments, thereby reducing unnecessary procedures and improving outcomes. By combining radiomics with advanced neural networks, they have demonstrated that subtle imaging features can serve as reliable biomarkers for genetic mutations. This work not only advances personalized medicine but also opens new avenues for AI-driven cancer diagnostics. Dr. Xiao’s contributions are particularly valuable for students and researchers interested in translational AI, as their methodology bridges computational innovation with real-world clinical needs, offering a template for future noninvasive genomic prediction studies.
Research Focus
Key Achievements
Top Papers
- 1